|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000260027 |
Summary for HOXB7 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000260027 | Gene symbol | HOXB7 |
| Gene name | homeobox B7 | |
| HGNC | 5118 | |
| Entrez ID | 3217 | |
| Gene type | protein_coding | |
| Synonyms | HOXB7| | |
| UniProtAcc | P09629 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for HOXB7 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| HOXB7 | 1.43e+03 | 1.62e+00 | 3.04e-01 | 5.31e+00 | 1.07e-07 | 1.08e-06 | BLCA |
| HOXB7 | 1.13e+03 | 1.79e+00 | 3.45e-01 | 5.18e+00 | 2.24e-07 | 6.95e-06 | ESCA |
| HOXB7 | 3.72e+02 | 3.99e+00 | 9.81e-01 | 4.07e+00 | 4.78e-05 | 2.29e-04 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| HOXB7 | 1.07e+03 | -1.14e+00 | 1.77e-01 | -6.43e+00 | 1.24e-10 | 8.05e-10 | KIRC |
| HOXB7 | 1.33e+03 | 1.16e+00 | 3.20e-01 | 3.62e+00 | 2.93e-04 | 2.13e-03 | STAD |
| HOXB7 | 7.93e+01 | 2.26e+00 | 3.88e-01 | 5.83e+00 | 5.66e-09 | 4.67e-08 | LIHC |
Top |
Sex-biased somatic mutation for HOXB7 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for HOXB7 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LIHC | cg10432569 | chr17:48632496 | CGI:chr17:48633593-48634057 | promoter,gene body | 4.07e-01 | 2.97e-01 | 2.99e+00 | 2.76e-03 | 7.47e-03 | 1.10e-01 |
| SARC | cg01452847 | chr17:48633979 | CGI:chr17:48633593-48634057 | promoter | 2.83e-01 | 1.80e-01 | 2.83e+00 | 4.60e-03 | 1.08e-02 | 1.02e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUSC | cg26608174 | chr17:48633673 | CGI:chr17:48633593-48634057 | promoter | 4.66e-01 | 1.14e-01 | 3.94e+00 | 8.07e-05 | 6.42e-04 | 3.51e-01 |
| LUSC | cg01132893 | chr17:48634724 | CGI:chr17:48633593-48634057 | promoter | 7.62e-01 | 3.78e-01 | 4.42e+00 | 9.95e-06 | 5.26e-04 | 3.84e-01 |
| LUSC | cg23690166 | chr17:48633655 | CGI:chr17:48633593-48634057 | promoter | 5.44e-01 | 1.05e-01 | 3.96e+00 | 7.60e-05 | 6.28e-04 | 4.38e-01 |
| LUSC | cg01452847 | chr17:48633979 | CGI:chr17:48633593-48634057 | promoter | 5.28e-01 | 1.20e-01 | 3.88e+00 | 1.06e-04 | 7.14e-04 | 4.08e-01 |
| LUSC | cg22851691 | chr17:48634084 | CGI:chr17:48633593-48634057 | promoter | 5.37e-01 | 1.17e-01 | 4.22e+00 | 2.44e-05 | 5.26e-04 | 4.20e-01 |
| LUSC | cg10432569 | chr17:48632496 | CGI:chr17:48633593-48634057 | promoter,gene body | 6.04e-01 | 3.66e-01 | 3.09e+00 | 2.03e-03 | 4.23e-03 | 2.38e-01 |
| LUSC | cg02329038 | chr17:48632639 | CGI:chr17:48633593-48634057 | promoter,gene body | 5.91e-01 | 3.18e-01 | 3.78e+00 | 1.58e-04 | 8.61e-04 | 2.73e-01 |
| LUSC | cg04735310 | chr17:48633689 | CGI:chr17:48633593-48634057 | promoter | 4.34e-01 | 1.82e-01 | 4.27e+00 | 1.94e-05 | 5.26e-04 | 2.53e-01 |
| LUSC | cg02462868 | chr17:48634690 | CGI:chr17:48633593-48634057 | promoter | 8.12e-01 | 5.22e-01 | 4.41e+00 | 1.04e-05 | 5.26e-04 | 2.90e-01 |
| BLCA | cg01132893 | chr17:48634724 | CGI:chr17:48633593-48634057 | promoter | 7.80e-01 | 5.53e-01 | 4.01e+00 | 6.06e-05 | 2.82e-04 | 2.27e-01 |
| BLCA | cg02462868 | chr17:48634690 | CGI:chr17:48633593-48634057 | promoter | 8.40e-01 | 7.25e-01 | 3.35e+00 | 7.95e-04 | 1.90e-03 | 1.15e-01 |
| ESCA | cg01132893 | chr17:48634724 | CGI:chr17:48633593-48634057 | promoter | 6.17e-01 | 3.54e-01 | 2.56e+00 | 1.04e-02 | 3.64e-02 | 2.63e-01 |
| ESCA | cg10432569 | chr17:48632496 | CGI:chr17:48633593-48634057 | promoter,gene body | 6.58e-01 | 3.83e-01 | 2.82e+00 | 4.81e-03 | 3.42e-02 | 2.75e-01 |
| ESCA | cg02462868 | chr17:48634690 | CGI:chr17:48633593-48634057 | promoter | 6.72e-01 | 4.75e-01 | 2.44e+00 | 1.46e-02 | 3.80e-02 | 1.97e-01 |
| CHOL | cg26608174 | chr17:48633673 | CGI:chr17:48633593-48634057 | promoter | 4.14e-01 | 1.29e-01 | 2.06e+00 | 3.90e-02 | 4.26e-02 | 2.84e-01 |
| CHOL | cg01132893 | chr17:48634724 | CGI:chr17:48633593-48634057 | promoter | 7.59e-01 | 3.69e-01 | 3.54e+00 | 4.02e-04 | 8.32e-03 | 3.90e-01 |
| CHOL | cg23690166 | chr17:48633655 | CGI:chr17:48633593-48634057 | promoter | 4.97e-01 | 1.11e-01 | 2.80e+00 | 5.09e-03 | 1.63e-02 | 3.86e-01 |
| CHOL | cg01452847 | chr17:48633979 | CGI:chr17:48633593-48634057 | promoter | 5.20e-01 | 1.02e-01 | 2.65e+00 | 7.96e-03 | 1.92e-02 | 4.19e-01 |
| CHOL | cg22851691 | chr17:48634084 | CGI:chr17:48633593-48634057 | promoter | 4.41e-01 | 1.85e-01 | 2.29e+00 | 2.23e-02 | 3.24e-02 | 2.56e-01 |
| CHOL | cg10432569 | chr17:48632496 | CGI:chr17:48633593-48634057 | promoter,gene body | 6.25e-01 | 2.68e-01 | 1.99e+00 | 4.65e-02 | 4.65e-02 | 3.57e-01 |
| CHOL | cg02329038 | chr17:48632639 | CGI:chr17:48633593-48634057 | promoter,gene body | 6.40e-01 | 2.71e-01 | 3.54e+00 | 4.02e-04 | 8.32e-03 | 3.69e-01 |
| CHOL | cg02462868 | chr17:48634690 | CGI:chr17:48633593-48634057 | promoter | 7.61e-01 | 4.79e-01 | 3.54e+00 | 4.02e-04 | 8.32e-03 | 2.81e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg26608174 | chr17:48633673 | CGI:chr17:48633593-48634057 | promoter | 4.09e-01 | 1.24e-01 | 1.17e+01 | 7.61e-32 | 1.40e-30 | 2.86e-01 |
| BRCA | cg01132893 | chr17:48634724 | CGI:chr17:48633593-48634057 | promoter | 8.60e-01 | 7.14e-01 | 1.16e+01 | 5.87e-31 | 9.65e-30 | 1.45e-01 |
| BRCA | cg23690166 | chr17:48633655 | CGI:chr17:48633593-48634057 | promoter | 4.68e-01 | 1.19e-01 | 1.14e+01 | 3.75e-30 | 5.57e-29 | 3.50e-01 |
| BRCA | cg01452847 | chr17:48633979 | CGI:chr17:48633593-48634057 | promoter | 4.92e-01 | 1.16e-01 | 1.28e+01 | 2.12e-37 | 9.54e-36 | 3.76e-01 |
| BRCA | cg22851691 | chr17:48634084 | CGI:chr17:48633593-48634057 | promoter | 4.53e-01 | 1.64e-01 | 1.17e+01 | 1.92e-31 | 3.34e-30 | 2.89e-01 |
| BRCA | cg04735310 | chr17:48633689 | CGI:chr17:48633593-48634057 | promoter | 3.46e-01 | 1.90e-01 | 1.09e+01 | 1.49e-27 | 1.63e-26 | 1.56e-01 |
| KIRC | cg22851691 | chr17:48634084 | CGI:chr17:48633593-48634057 | promoter | 2.97e-01 | 4.45e-01 | -2.32e+00 | 2.06e-02 | 2.75e-02 | -1.48e-01 |
| LUAD | cg02329038 | chr17:48632639 | CGI:chr17:48633593-48634057 | promoter,gene body | 4.88e-01 | 3.25e-01 | 2.76e+00 | 5.80e-03 | 1.07e-02 | 1.62e-01 |
| LIHC | cg22851691 | chr17:48634084 | CGI:chr17:48633593-48634057 | promoter | 2.85e-01 | 1.23e-01 | 2.95e+00 | 3.19e-03 | 5.63e-03 | 1.62e-01 |
| LIHC | cg02462868 | chr17:48634690 | CGI:chr17:48633593-48634057 | promoter | 6.83e-01 | 4.89e-01 | 4.23e+00 | 2.29e-05 | 1.27e-04 | 1.94e-01 |
Top |
Exon skipping events with PSI in TCGA for HOXB7 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for HOXB7 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for HOXB7 |
| TFs related to HOXB7. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| HOXB7 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
 |
Top |
Sex-biased RBP-ES network for HOXB7 |
| RBPs related to ES in HOXB7. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| HOXB7 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs41456547 | chr17:51168984:T:G | - | 0.270893350533615 | 0.0130689244271302 | GBM | Female-baised eQTL |
| rs75711442 | chr17:51167724:C:G | - | 0.23201652231516 | 0.0392576648742766 | GBM | Female-baised eQTL |
| rs7217557 | chr17:51164819:G:C | - | 0.228911371230048 | 0.0466715591702612 | GBM | Female-baised eQTL |
| rs4319829 | chr17:58249495:C:T | - | 0.194046572037592 | 1.73878796640814e-05 | BLCA | Female-baised eQTL |
| rs79758134 | chr17:58215453:G:A | - | 0.177497169397883 | 0.000124355033952667 | BLCA | Female-baised eQTL |
| rs185365752 | chr17:58218250:A:C | - | 0.176197594789425 | 0.000152496384628101 | BLCA | Female-baised eQTL |
| rs150316670 | chr17:58222905:C:T | - | 0.176197594789425 | 0.000152496384628101 | BLCA | Female-baised eQTL |
| rs149311760 | chr17:58222998:C:T | - | 0.176197594789425 | 0.000152496384628101 | BLCA | Female-baised eQTL |
| rs76990280 | chr17:58225825:G:A | - | 0.176197594789425 | 0.000152496384628101 | BLCA | Female-baised eQTL |
| rs117502217 | chr17:58228839:G:A | - | 0.176197594789425 | 0.000152496384628101 | BLCA | Female-baised eQTL |
| rs115576510 | chr17:58257223:C:T | - | 0.171616246057329 | 0.000364488812371689 | BLCA | Female-baised eQTL |
| rs8178390 | chr17:58262696:T:C | - | 0.171616246057329 | 0.000364488812371689 | BLCA | Female-baised eQTL |
| rs11867630 | chr17:58234391:A:C | - | 0.156519611448731 | 0.00171380805889787 | BLCA | Female-baised eQTL |
| rs8178298 | chr17:58244649:C:T | - | 0.156144383767098 | 0.00183367940961294 | BLCA | Female-baised eQTL |
| rs8178329 | chr17:58249160:G:C | - | 0.156144383767098 | 0.00183367940961294 | BLCA | Female-baised eQTL |
| rs57926249 | chr17:58210440:G:A | - | 0.141656134451993 | 0.00480242750935048 | BLCA | Female-baised eQTL |
| rs28689858 | chr17:46054002:T:C | - | -0.130058234377076 | 0.0331008572088569 | BLCA | Female-baised eQTL |
| rs975251 | chr17:41251089:G:T | - | -0.109497536751996 | 0.0403069887024785 | BLCA | Female-baised eQTL |
| rs2320363 | chr17:41236579:G:A | - | -0.111309557416017 | 0.0404474120208329 | BLCA | Female-baised eQTL |
| rs4890159 | chr17:41242873:C:A | - | -0.111309557416017 | 0.0404474120208329 | BLCA | Female-baised eQTL |
| rs4057758 | chr17:41250337:A:G | - | -0.111309557416017 | 0.0404474120208329 | BLCA | Female-baised eQTL |
| rs4890166 | chr17:41280386:G:A | - | -0.111309557416017 | 0.0404474120208329 | BLCA | Female-baised eQTL |
| rs11657301 | chr17:41283731:G:T | - | -0.111309557416017 | 0.0404474120208329 | BLCA | Female-baised eQTL |
| rs6503619 | chr17:41289881:T:C | - | -0.111309557416017 | 0.0404474120208329 | BLCA | Female-baised eQTL |
| rs8079152 | chr17:41292186:T:C | - | -0.111309557416017 | 0.0404474120208329 | BLCA | Female-baised eQTL |
| rs2009903 | chr17:41292803:C:A | - | -0.111309557416017 | 0.0404474120208329 | BLCA | Female-baised eQTL |
| rs2041392 | chr17:41293687:G:A | - | -0.111309557416017 | 0.0404474120208329 | BLCA | Female-baised eQTL |
| rs8078770 | chr17:41296870:A:C | - | -0.111309557416017 | 0.0404474120208329 | BLCA | Female-baised eQTL |
| rs887484 | chr17:41300146:T:C | - | -0.111309557416017 | 0.0404474120208329 | BLCA | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs4541106 | chr17:38915939:T:G | - | 0.0812429047030963 | 0.00825726491597015 | KIRC | Male-baised eQTL |
| rs4792833 | chr17:46142008:C:A | - | 0.108159853914026 | 0.0224696265619691 | BLCA | Male-baised eQTL |
| rs2957313 | chr17:46254939:G:A | - | 0.106206742652522 | 0.0266050720384478 | BLCA | Male-baised eQTL |
| rs4792834 | chr17:46142126:T:C | - | 0.106069175424677 | 0.0281028697496644 | BLCA | Male-baised eQTL |
| rs12603341 | chr17:46119464:G:A | - | 0.105715442470394 | 0.0291284202650958 | BLCA | Male-baised eQTL |
| rs1968120 | chr17:46191587:A:G | - | 0.1052432639253 | 0.0306725906341272 | BLCA | Male-baised eQTL |
| rs3826295 | chr17:56862376:T:A | - | 0.0570345616759002 | 0.0314352385759593 | BLCA | Male-baised eQTL |
| rs8071009 | chr17:56863030:A:G | - | 0.056571327271104 | 0.0342768190714654 | BLCA | Male-baised eQTL |
| rs1992554 | chr17:56864155:C:T | - | 0.056571327271104 | 0.0342768190714654 | BLCA | Male-baised eQTL |
| rs9911132 | chr17:56865362:A:C | - | 0.056571327271104 | 0.0342768190714654 | BLCA | Male-baised eQTL |
| rs9893721 | chr17:56866621:T:C | - | 0.056571327271104 | 0.0342768190714654 | BLCA | Male-baised eQTL |
| rs9892659 | chr17:56866725:G:A | - | 0.056571327271104 | 0.0342768190714654 | BLCA | Male-baised eQTL |
| rs9897759 | chr17:56863555:T:A | - | 0.0563880105506832 | 0.0358628552321741 | BLCA | Male-baised eQTL |
| rs35282812 | chr17:56859274:A:G | - | 0.0561599462799548 | 0.0373778675909055 | BLCA | Male-baised eQTL |
| rs8074637 | chr17:56860306:G:A | - | 0.0561599462799548 | 0.0373778675909055 | BLCA | Male-baised eQTL |
| rs6503774 | chr17:56841479:C:G | - | 0.055156172556211 | 0.041140701917982 | BLCA | Male-baised eQTL |
| rs9913602 | chr17:56844665:C:A | - | 0.0556317970479262 | 0.0415303848120525 | BLCA | Male-baised eQTL |
| rs12601782 | chr17:56849464:G:A | - | 0.0555944387926846 | 0.0426292031416504 | BLCA | Male-baised eQTL |
| rs7223066 | chr17:56839610:C:G | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs9905199 | chr17:56840278:T:C | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs6503773 | chr17:56840540:C:T | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs7210030 | chr17:56841020:G:A | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs3959524 | chr17:56841988:G:A | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs9899453 | chr17:56842627:T:C | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs7225346 | chr17:56843583:A:C | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs3760157 | chr17:56843961:G:A | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs3760158 | chr17:56844133:A:C | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs2176744 | chr17:56844977:G:A | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs2049061 | chr17:56845296:G:A | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs2078517 | chr17:56846654:T:A | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs2271898 | chr17:56848977:C:T | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs4794671 | chr17:56850915:C:T | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs4794672 | chr17:56851225:G:A | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs4793835 | chr17:56851481:C:G | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs9907968 | chr17:56852874:G:A | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs9908291 | chr17:56853166:C:G | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs9902250 | chr17:56855490:A:G | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs9903097 | chr17:56855657:G:A | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs9902931 | chr17:56855743:C:T | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs8067569 | chr17:56856955:G:A | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs8067906 | chr17:56857180:G:C | - | 0.0554551906739823 | 0.0428759148970765 | BLCA | Male-baised eQTL |
| rs9911560 | chr17:56862354:T:C | - | 0.0556660762948249 | 0.0437161001134457 | BLCA | Male-baised eQTL |
| rs4794673 | chr17:56870627:G:C | - | 0.0553727592297876 | 0.0449944338779321 | BLCA | Male-baised eQTL |
| rs12150106 | chr17:56867647:G:A | - | -0.0550561949509554 | 0.0450853542453277 | BLCA | Male-baised eQTL |
| rs12150100 | chr17:56867648:C:A | - | -0.0550561949509554 | 0.0450853542453277 | BLCA | Male-baised eQTL |
| rs8078200 | chr17:56867768:A:G | - | 0.0550561949509554 | 0.0450853542453277 | BLCA | Male-baised eQTL |
| rs8078230 | chr17:56867827:A:G | - | 0.0550561949509554 | 0.0450853542453277 | BLCA | Male-baised eQTL |
| rs7209070 | chr17:56868833:T:C | - | 0.0550561949509554 | 0.0450853542453277 | BLCA | Male-baised eQTL |
| rs2049062 | chr17:56845443:G:C | - | 0.0551506921105731 | 0.0456483096419361 | BLCA | Male-baised eQTL |
| rs7218364 | chr17:56854939:A:G | - | 0.0550863807473461 | 0.0462094530676347 | BLCA | Male-baised eQTL |
| rs62072709 | chr17:56859291:T:C | - | 0.0546398752144218 | 0.0489780303602139 | BLCA | Male-baised eQTL |
| rs9890787 | chr17:52367371:G:A | - | 0.0462980704507195 | 0.0172649016440696 | COAD | Male-baised eQTL |
| rs7207963 | chr17:52367155:C:G | - | 0.0448259884974896 | 0.0221397071520215 | COAD | Male-baised eQTL |
| rs11080002 | chr17:52368174:G:C | - | -0.0425246161354942 | 0.0433477666146364 | COAD | Male-baised eQTL |
| rs4479296 | chr17:51596648:G:T | - | 0.0844993331777691 | 0.0457752337916769 | COAD | Male-baised eQTL |
| rs34087631 | chr17:51609595:G:A | - | 0.0849504163314553 | 0.0477567097139393 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000260027 |
| CpG Site: cg23245942 | |
| Position to Gene: gene | |
| Male Effect: -0.487795654599 | |
| Female Effect: - | |
 | Gene ID: ENSG00000260027 |
| CpG Site: cg04917446 | |
| Position to Gene: gene | |
| Male Effect: -0.487795654599 | |
| Female Effect: - | |
 | Gene ID: ENSG00000260027 |
| CpG Site: cg15117739 | |
| Position to Gene: gene | |
| Male Effect: -0.236357136842829 | |
| Female Effect: - | |
 | Gene ID: ENSG00000260027 |
| CpG Site: cg07547765 | |
| Position to Gene: gene,exon,CDS | |
| Male Effect: -0.345325413996697 | |
| Female Effect: - | |
 | Gene ID: ENSG00000260027 |
| CpG Site: cg18773260 | |
| Position to Gene: gene,exon,CDS | |
| Male Effect: -0.216754361768548 | |
| Female Effect: - | |
 | Gene ID: ENSG00000260027 |
| CpG Site: cg02462868 | |
| Position to Gene: promoter | |
| Male Effect: - | |
| Female Effect: -0.423307818143103 | |
 | Gene ID: ENSG00000260027 |
| CpG Site: cg01132893 | |
| Position to Gene: promoter | |
| Male Effect: - | |
| Female Effect: -0.423307818143103 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg23245942 | chr17:48621611 | gene | -0.487795654599 | 5.98026053853709e-23 | -0.8910404162103555 | 1.769657060158688e-28 | LAML |
| cg04917446 | chr17:48621711 | gene | -0.487795654599 | 5.98026053853709e-23 | -0.8910404162103555 | 1.769657060158688e-28 | LAML |
| cg15117739 | chr17:48621519 | gene | -0.236357136842829 | 8.00714340143059e-06 | -0.6135263873600731 | 1.4422095937934552e-09 | LAML |
| cg07547765 | chr17:48608086 | gene,exon,CDS | -0.345325413996697 | 3.9193741210168e-18 | -0.5814409391915246 | 1.447065036177911e-21 | LUAD |
| cg18773260 | chr17:48607930 | gene,exon,CDS | -0.216754361768548 | 6.84202220919259e-06 | -0.3087611964296514 | 3.6867899039391605e-08 | BLCA |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg02462868 | chr17:48634690 | promoter | -0.423307818143103 | 4.86590682084492e-15 | -0.7252142991640966 | 4.781175924927774e-19 | BLCA |
| cg01132893 | chr17:48634724 | promoter | -0.423307818143103 | 4.86590682084492e-15 | -0.7252142991640966 | 4.781175924927774e-19 | BLCA |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of HOXB7 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
